189 related articles for article (PubMed ID: 28527270)
21. Role of spiramycin in prevention of fetal toxoplasmosis.
Avci ME; Arslan F; Çiftçi Ş; Ekiz A; Tüten A; Yildirim G; Madazli R
J Matern Fetal Neonatal Med; 2016; 29(13):2073-6. PubMed ID: 26365472
[TBL] [Abstract][Full Text] [Related]
22. [Toxoplasmosis in pregnancy: Practical Management].
Mandelbrot L; Kieffer F; Wallon M; Winer N; Massardier J; Picone O; Fuchs F; Benoist G; Garcia-Meric P; L'Ollivier C; Paris L; Piarroux R; Villena I; Peyron F
Gynecol Obstet Fertil Senol; 2021 Oct; 49(10):782-791. PubMed ID: 33677120
[TBL] [Abstract][Full Text] [Related]
23. Spiramycin/cotrimoxazole versus pyrimethamine/sulfonamide and spiramycin alone for the treatment of toxoplasmosis in pregnancy.
Valentini P; Buonsenso D; Barone G; Serranti D; Calzedda R; Ceccarelli M; Speziale D; Ricci R; Masini L
J Perinatol; 2015 Feb; 35(2):90-4. PubMed ID: 25211284
[TBL] [Abstract][Full Text] [Related]
24. Management of Toxoplasma gondii infection during pregnancy.
Montoya JG; Remington JS
Clin Infect Dis; 2008 Aug; 47(4):554-66. PubMed ID: 18624630
[TBL] [Abstract][Full Text] [Related]
25. Long-term ocular outcome in congenital toxoplasmosis: a prospective cohort of treated children.
Faucher B; Garcia-Meric P; Franck J; Minodier P; Francois P; Gonnet S; L'ollivier C; Piarroux R
J Infect; 2012 Jan; 64(1):104-9. PubMed ID: 22051915
[TBL] [Abstract][Full Text] [Related]
26. [Monitoring and treatment of toxoplasmosis in the pregnant woman, fetus and newborn].
Garin JP; Mojon M; Piens MA; Chevalier-Nuttall I
Pediatrie; 1989; 44(9):705-12. PubMed ID: 2695891
[TBL] [Abstract][Full Text] [Related]
27. [Congenital toxoplasmosis. Report of a case treated with spiramycin in the 24th week of pregnancy].
Di Taranto G; Gava G; Dal Pozzo G; Adamo W; Fontana M
Minerva Ginecol; 1991 Nov; 43(11):533-6. PubMed ID: 1784412
[TBL] [Abstract][Full Text] [Related]
28. Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis.
Brézin AP; Thulliez P; Couvreur J; Nobré R; Mcleod R; Mets MB
Am J Ophthalmol; 2003 Jun; 135(6):779-84. PubMed ID: 12788116
[TBL] [Abstract][Full Text] [Related]
29. [Toxoplasmosis and pregnancy: is it possible to simplify the diagnostic procedures?].
Roth P; Maillet R; Dalphin ML; Schaal JP; Colette C
J Gynecol Obstet Biol Reprod (Paris); 1993; 22(3):277-83. PubMed ID: 8345152
[TBL] [Abstract][Full Text] [Related]
30. Management of toxoplasmosis.
Georgiev VS
Drugs; 1994 Aug; 48(2):179-88. PubMed ID: 7527323
[TBL] [Abstract][Full Text] [Related]
31. Long-term outcome of children with congenital toxoplasmosis.
Berrébi A; Assouline C; Bessières MH; Lathière M; Cassaing S; Minville V; Ayoubi JM
Am J Obstet Gynecol; 2010 Dec; 203(6):552.e1-6. PubMed ID: 20633868
[TBL] [Abstract][Full Text] [Related]
32. [Fetomaternal therapeutic follow-up of spiramycin during pregnancy].
Forestier F; Daffos F; Rainaut M; Desnottes JF; Gaschard JC
Arch Fr Pediatr; 1987; 44(7):539-44. PubMed ID: 3426376
[TBL] [Abstract][Full Text] [Related]
33. Congenital toxoplasmosis: efficacy of maternal treatment with spiramycin alone.
Vergani P; Ghidini A; Ceruti P; Strobelt N; Spelta A; Zapparoli B; Rescaldani R
Am J Reprod Immunol; 1998 May; 39(5):335-40. PubMed ID: 9602252
[TBL] [Abstract][Full Text] [Related]
34. What is known about the prevention of congenital toxoplasmosis?
Jeannel D; Costagliola D; Niel G; Hubert B; Danis M
Lancet; 1990 Aug; 336(8711):359-61. PubMed ID: 1975344
[TBL] [Abstract][Full Text] [Related]
35. Results of a preventive program for congenital toxoplasmosis.
Ghidini A; Sirtori M; Spelta A; Vergani P
J Reprod Med; 1991 Apr; 36(4):270-3. PubMed ID: 2072359
[TBL] [Abstract][Full Text] [Related]
36. Congenital toxoplasmosis--prenatal aspects of Toxoplasma gondii infection.
Rorman E; Zamir CS; Rilkis I; Ben-David H
Reprod Toxicol; 2006 May; 21(4):458-72. PubMed ID: 16311017
[TBL] [Abstract][Full Text] [Related]
37. [Management of congenital toxoplasmosis in France: current data].
Garcia-Méric P; Franck J; Dumon H; Piarroux R
Presse Med; 2010 May; 39(5):530-8. PubMed ID: 19926248
[TBL] [Abstract][Full Text] [Related]
38. [Congenital toxoplasmosis: severe ocular and neurological complications].
Hoekstra F; Buzing C; Sporken JM; Erasmus CE; van der Flier M; Semmekrot BA
Ned Tijdschr Geneeskd; 2011; 155(18):A2853. PubMed ID: 21557824
[TBL] [Abstract][Full Text] [Related]
39. Long-term Ocular Outcomes in Congenital Toxoplasmosis Treated Perinatally.
Journé A; Garweg J; Ksiazek E; Peyron F; Binquet C; Wallon M
Pediatrics; 2024 Apr; 153(4):. PubMed ID: 38454832
[TBL] [Abstract][Full Text] [Related]
40. [Theoretical bases of the prevention by spiramycin of congenital toxoplasmosis in pregnant women].
Garin JP; Pellerat J; Maillard ; Woehrle R; Hezez
Presse Med (1893); 1968 Dec; 76(48):2266. PubMed ID: 5720932
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
